We are live on ! Find out more
ECM

EagleClaw Capital Management Portfolio holdings

AUM $714M
1-Year Est. Return 24.24%
This Fund
S&P 500
This Quarter Est. Return
-2.3%
1 Year Est. Return
+24.24%
3 Year Est. Return
+96.54%
5 Year Est. Return
+138.84%
10 Year Est. Return
+573.51%
AUM
$435M
AUM Growth
-$20.9M
Cap. Flow
-$549K
Cap. Flow %
-0.13%
Top 10 Hldgs %
34.54%
Holding
144
New
2
Increased
34
Reduced
63
Closed
9

Top Buys

Rank Stock Value
1
PH icon
Parker-Hannifin
PH
+$4.22M
2
CRL icon
Charles River Laboratories
CRL
+$3.13M
3
APD icon
Air Products & Chemicals
APD
+$851K
4
GEN icon
Gen Digital
GEN
+$562K
5
JPM icon
JPMorgan Chase
JPM
+$425K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$2.57M
2
NVDA icon
NVIDIA
NVDA
+$1.14M
3
DIS icon
Walt Disney
DIS
+$1.08M
4
ARMK icon
Aramark
ARMK
+$525K
5
AMZN icon
Amazon
AMZN
+$442K

Sector Composition

Rank Sector Weight
1 Technology 20.12%
2 Consumer Discretionary 17.42%
3 Healthcare 12.52%
4 Financials 11.93%
5 Industrials 11.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AIG icon
51
American International
AIG
$41.8B
$2.78M 0.64%
44,350
-600
-1% -$36.1K
HON icon
52
Honeywell
HON
$78.2B
$2.7M 0.62%
14,733
+196
+1% +$36.3K
MRK icon
53
Merck
MRK
$316B
$2.62M 0.6%
31,961
+179
+0.6% +$14.1K
MSGS icon
54
Madison Square Garden
MSGS
$9.27B
$2.51M 0.58%
13,975
-200
-1% -$34.1K
FISV
55
Fiserv Inc
FISV
$29B
$2.46M 0.56%
24,210
+2,775
+13% +$281K
CVS icon
56
CVS Health
CVS
$134B
$2.42M 0.56%
23,937
-3,975
-14% -$418K
TXN icon
57
Texas Instruments
TXN
$246B
$2.33M 0.54%
12,720
-25
-0.2% -$4.41K
EMR icon
58
Emerson Electric
EMR
$86.7B
$2.33M 0.53%
23,747
-400
-2% -$37.9K
CL icon
59
Colgate-Palmolive
CL
$71.6B
$2.31M 0.53%
30,519
-335
-1% -$26.5K
IBM icon
60
IBM
IBM
$213B
$2.3M 0.53%
17,660
-35
-0.2% -$4.56K
MKC icon
61
McCormick & Company Non-Voting
MKC
$13.9B
$2.18M 0.5%
21,850
-30
-0.1% -$2.93K
NVS icon
62
Novartis
NVS
$292B
$2.18M 0.5%
24,810
-150
-0.6% -$13K
COP icon
63
ConocoPhillips
COP
$145B
$2.07M 0.47%
20,662
+1,075
+5% +$98.9K
VRTX icon
64
Vertex Pharmaceuticals
VRTX
$119B
$1.94M 0.45%
7,440
– –
INFL icon
65
Horizon Kinetics Inflation Beneficiaries ETF
INFL
$1.51B
$1.92M 0.44%
57,550
+9,875
+21% +$311K
SIVB
66
DELISTED
SVB Financial Group
SIVB
$1.89M 0.43%
3,371
– –
BDX icon
67
Becton Dickinson
BDX
$46.9B
$1.82M 0.42%
7,005
– –
PFE icon
68
Pfizer
PFE
$143B
$1.54M 0.35%
29,734
-825
-3% -$42.8K
UNP icon
69
Union Pacific
UNP
$173B
$1.43M 0.33%
5,241
-75
-1% -$18.9K
WMB icon
70
Williams Companies
WMB
$86.1B
$1.34M 0.31%
40,000
– –
AFL icon
71
Aflac
AFL
$64.5B
$1.32M 0.3%
20,463
-300
-1% -$18.8K
CLNE icon
72
Clean Energy Fuels
CLNE
$410M
$1.26M 0.29%
158,500
+550
+0.3% +$3.71K
VO icon
73
Vanguard Morningstar Mid-Cap ETF
VO
$108B
$1.17M 0.27%
19,600
– –
CSGP icon
74
CoStar Group
CSGP
$12.2B
$1.15M 0.26%
17,310
– –
INGR icon
75
Ingredion
INGR
$6.33B
$1.14M 0.26%
13,100
-300
-2% -$27.2K
1 2
3
4 5

Similar funds

GEA
Glen Eagle Advisors Kingston, New Jersey $714M AUM 18.87% 1-Year Est. Return
ACGDR
Atmos Capital Gestao de Recursos Leblon - Rio De Janeiro, Brazil $714M AUM 35.97% 1-Year Est. Return
CFGSD
Compass Financial Group (South Dakota) Sioux Falls, South Dakota $715M AUM 15.96% 1-Year Est. Return
LFA
Legacy Financial Advisors Covington, Kentucky $715M AUM 22.34% 1-Year Est. Return
IWP
Insight Wealth Partners Plano, Texas $713M AUM 16.55% 1-Year Est. Return
DCM
Dimension Capital Management Coral Gables, Florida $713M AUM 18.57% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $716M AUM 21.09% 1-Year Est. Return
TLP
Tri Locum Partners New York $713M AUM 68.92% 1-Year Est. Return

EagleClaw Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, EagleClaw Capital Management held 144 positions worth $435M, down 4.6% from $456M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

EagleClaw Capital Management's Q1 2022 filing shows 2 new, 34 increased, 63 reduced and 9 closed positions. Its largest new stake was Parker-Hannifin: 13,995 shares worth $3.97M. The largest sale was Apple, an estimated $2.57M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • EagleClaw Capital Management's largest Q1 2022 buy was Parker-Hannifin: 13,995 shares worth $3.97M.
  • EagleClaw Capital Management added most to Charles River Laboratories in Q1 2022, an estimated $3.13M increase.
  • EagleClaw Capital Management's biggest Q1 2022 reduction was Apple, cutting an estimated $2.57M.
  • EagleClaw Capital Management fully exited Aramark in Q1 2022, selling an estimated $525K.
  • EagleClaw Capital Management's ten largest holdings make up 35% of its $435M portfolio in Q1 2022.
  • EagleClaw Capital Management opened 2 new positions and closed 9 in Q1 2022.
  • EagleClaw Capital Management's portfolio value fell 4.6% quarter-over-quarter to $435M.

Based on EagleClaw Capital Management's 13F filing for Q1 2022, filed 13 May 2022.